Reducedhumoral response against variants of concern in childhood solid cancer patients compared to adult patients and healthy children after SARS-CoV-2 vaccination
暂无分享,去创建一个
A. Zhang | Nianqi Liu | Yifei Ma | Xinjia Wang | P. Zhu | Youlong Wang | Shenrui Bai | Guangzhen Fu | Yanqi Wang | Dao-Qing Wang | Zhiying Zhang | G. Zhong | Lu Cao | Shuqin Chen | Bocen Chen | Jun Lv | Xiaolong Wei
[1] W. Jantarabenjakul,et al. Immune Response after 2 Doses of BNT162b2 mRNA COVID-19 Vaccinations in Children and Adolescents with Cancer and Hematologic Diseases , 2022, Asian Pacific journal of cancer prevention : APJCP.
[2] D. Micic,et al. Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis , 2022, Journal of Hematology & Oncology.
[3] L. Pickering,et al. Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer , 2022, The Lancet.
[4] Emily E. Johnston,et al. SARS‐CoV‐2 vaccine acceptability among caregivers of childhood cancer survivors , 2021, Pediatric blood & cancer.
[5] Lei Zhao,et al. Prevalence and Impact Factors of COVID-19 Vaccination Hesitancy Among Breast Cancer Survivors: A Multicenter Cross-Sectional Study in China , 2021, Frontiers in Medicine.
[6] Nianqi Liu,et al. Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis , 2021, Journal for ImmunoTherapy of Cancer.
[7] P. Nathan,et al. Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor , 2021, Cancer.
[8] R. Kotecha. COVID‐19 vaccination for children with cancer , 2021, Pediatric blood & cancer.
[9] N. André,et al. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study , 2021, The Lancet Oncology.
[10] Changgui Li,et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial , 2021, The Lancet Infectious Diseases.
[11] P. Dormitzer,et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents , 2021, The New England journal of medicine.
[12] M. Malim,et al. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study , 2021, The Lancet Oncology.
[13] G. Pravettoni,et al. Current Perspectives: SARS-CoV-2 vaccines for cancer patients: a call to action , 2021, European Journal of Cancer.
[14] Arthur S Slutsky,et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. , 2020, JAMA.
[15] Daniel K Choi,et al. Vaccination in pediatric cancer survivors: Vaccination rates, immune status, and knowledge regarding compliance , 2020, Pediatric blood & cancer.
[16] R. Kotecha. Challenges posed by COVID-19 to children with cancer , 2020, The Lancet Oncology.
[17] Elizabeth M. Wells,et al. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort. , 2018, The Lancet. Oncology.
[18] Gang Liu,et al. A cohort study , 2018 .
[19] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[20] C. Blyth,et al. Immunogenicity and safety of single‐dose, 13‐valent pneumococcal conjugate vaccine in pediatric and adolescent oncology patients , 2017, Cancer.
[21] I. Barr,et al. Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer , 2015, Cancer medicine.
[22] D. Bates,et al. Linear Mixed-Effects Models using 'Eigen' and S4 , 2015 .
[23] P. Nathan,et al. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort. , 2014, The Lancet. Oncology.
[24] L. Kremer,et al. Influenza vaccination in children being treated with chemotherapy for cancer. , 2013, The Cochrane database of systematic reviews.
[25] J. McCullers,et al. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. , 2011, The Journal of infectious diseases.
[26] P. Austin. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples , 2009, Statistics in medicine.
[27] Stefano M. Iacus,et al. cem: Software for Coarsened Exact Matching , 2009, Journal of Statistical Software.
[28] F. Schmidt. Meta-Analysis , 2008 .
[29] Gary King,et al. Matching as Nonparametric Preprocessing for Reducing Model Dependence in Parametric Causal Inference , 2007, Political Analysis.
[30] Paul Tseng,et al. Relaxation Methods for Minimum Cost Ordinary and Generalized Network Flow Problems , 1988, Oper. Res..
[31] W. Conover. Statistical Methods for Rates and Proportions , 1974 .
[32] Hay Dn,et al. Call for action. , 1971, Nursing mirror and midwives journal.
[33] Tingting Li,et al. The long-term impact of tumor burden in pT3N0M0 esophageal squamous cell carcinoma , 2019, Medicine.